Medicare AdvantageCoverageHigh impact
MA08.012d, Off-label Coverage for Prescription Drugs and/or Biologics
Independence Blue Cross·Pharmacy
Effective date
Apr 1, 2026
We identified it
Jun 19, 2026
Summary
Policy MA08.012d establishes coverage criteria for off-label use of prescription drugs and biologics under Medicare Advantage plans, effective April 1, 2026. This reissued policy clarifies when off-label medications will be covered and likely requires prior authorization and medical necessity documentation. Billing teams must understand these criteria to avoid claim denials for off-label prescriptions.
Action Required
By March 15, 2026: Billing team and providers must review the complete policy text at the provided URL to identify specific off-label coverage criteria and any prior authorization requirements. Update billing software and prior authorization protocols to enforce coverage rules for off-label drugs and biologics. Train providers on documentation requirements needed to support off-label prescriptions. Flag all off-label medication claims for review before submission to ensure compliance with MA08.012d criteria. Failure to follow these requirements will result in claim denials for non-compliant off-label prescriptions.